Literature DB >> 28441061

Precisely Where Are We Going? Charting the New Terrain of Precision Prevention.

Karen M Meagher1, Michelle L McGowan2,3,4, Richard A Settersten5, Jennifer R Fishman6, Eric T Juengst7.   

Abstract

In addition to genetic data, precision medicine research gathers information about three factors that modulate gene expression: lifestyles, environments, and communities. The relevant research tools-epidemiology, environmental assessment, and socioeconomic analysis-are those of public health sciences rather than molecular biology. Because these methods are designed to support inferences and interventions addressing population health, the aspirations of this research are expanding from individualized treatment toward precision prevention in public health. The purpose of this review is to explore the emerging goals and challenges of such a shift to help ensure that the genomics community and public policy makers understand the ethical issues at stake in embracing and pursuing precision prevention. Two emerging goals bear special attention in this regard: (a) public health risk reduction strategies, such as screening, and (b) the application of genomic variation studies to understand and reduce health disparities among population groups.

Entities:  

Keywords:  ELSI; genomics; health disparities; precision medicine; prevention; public health

Mesh:

Year:  2017        PMID: 28441061      PMCID: PMC6203331          DOI: 10.1146/annurev-genom-091416-035222

Source DB:  PubMed          Journal:  Annu Rev Genomics Hum Genet        ISSN: 1527-8204            Impact factor:   8.929


  84 in total

Review 1.  Ethical and legal implications of pharmacogenomics.

Authors:  M A Rothstein; P G Epps
Journal:  Nat Rev Genet       Date:  2001-03       Impact factor: 53.242

Review 2.  How a drug becomes "ethnic": law, commerce, and the production of racial categories in medicine.

Authors:  Jonathan Kahn
Journal:  Yale J Health Policy Law Ethics       Date:  2004

3.  Public Health in the Precision-Medicine Era.

Authors:  Ronald Bayer; Sandro Galea
Journal:  N Engl J Med       Date:  2015-08-06       Impact factor: 91.245

Review 4.  Beyond race: towards a whole-genome perspective on human populations and genetic variation.

Authors:  Morris W Foster; Richard R Sharp
Journal:  Nat Rev Genet       Date:  2004-10       Impact factor: 53.242

5.  What we do and don't know about 'race', 'ethnicity', genetics and health at the dawn of the genome era.

Authors:  Francis S Collins
Journal:  Nat Genet       Date:  2004-11       Impact factor: 38.330

6.  State newborn screening in the tandem mass spectrometry era: more tests, more false-positive results.

Authors:  Beth A Tarini; Dimitri A Christakis; H Gilbert Welch
Journal:  Pediatrics       Date:  2006-08       Impact factor: 7.124

7.  Social determinants of health in the setting of hypertrophic cardiomyopathy.

Authors:  Jodie Ingles; Renee Johnson; Tanya Sarina; Laura Yeates; Charlotte Burns; Belinda Gray; Kylie Ball; Christopher Semsarian
Journal:  Int J Cardiol       Date:  2015-03-05       Impact factor: 4.164

8.  Integrating genomics into clinical oncology: ethical and social challenges from proponents of personalized medicine.

Authors:  Michelle L McGowan; Richard A Settersten; Eric T Juengst; Jennifer R Fishman
Journal:  Urol Oncol       Date:  2014-02       Impact factor: 3.498

9.  Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.

Authors:  Sarah S Kalia; Kathy Adelman; Sherri J Bale; Wendy K Chung; Christine Eng; James P Evans; Gail E Herman; Sophia B Hufnagel; Teri E Klein; Bruce R Korf; Kent D McKelvey; Kelly E Ormond; C Sue Richards; Christopher N Vlangos; Michael Watson; Christa L Martin; David T Miller
Journal:  Genet Med       Date:  2016-11-17       Impact factor: 8.822

Review 10.  We screen newborns, don't we?: realizing the promise of public health genomics.

Authors:  James P Evans; Jonathan S Berg; Andrew F Olshan; Terry Magnuson; Barbara K Rimer
Journal:  Genet Med       Date:  2013-03-07       Impact factor: 8.822

View more
  9 in total

Review 1.  Genomic medicine for kidney disease.

Authors:  Emily E Groopman; Hila Milo Rasouly; Ali G Gharavi
Journal:  Nat Rev Nephrol       Date:  2018-01-08       Impact factor: 28.314

2.  Adolescent and Parental Attitudes About Return of Genomic Research Results: Focus Group Findings Regarding Decisional Preferences.

Authors:  Michelle L McGowan; Cynthia A Prows; Melissa DeJonckheere; William B Brinkman; Lisa Vaughn; Melanie F Myers
Journal:  J Empir Res Hum Res Ethics       Date:  2018-05-28       Impact factor: 1.742

3.  Genomic Essentialism: Its Provenance and Trajectory as an Anticipatory Ethical Concern.

Authors:  Maya Sabatello; Eric Juengst
Journal:  Hastings Cent Rep       Date:  2019-05       Impact factor: 2.683

4.  Recommendations on the use and reporting of race, ethnicity, and ancestry in genetic research: Experiences from the NHLBI TOPMed program.

Authors:  Alyna T Khan; Stephanie M Gogarten; Caitlin P McHugh; Adrienne M Stilp; Tamar Sofer; Michael L Bowers; Quenna Wong; L Adrienne Cupples; Bertha Hidalgo; Andrew D Johnson; Merry-Lynn N McDonald; Stephen T McGarvey; Matthew R G Taylor; Stephanie M Fullerton; Matthew P Conomos; Sarah C Nelson
Journal:  Cell Genom       Date:  2022-07-26

5.  Nature vs. Nurture in Precision Education: Insights of Parents and the Public.

Authors:  Maya Sabatello; Bree Martin; Thomas Corbeil; Seonjoo Lee; Bruce G Link; Paul S Appelbaum
Journal:  AJOB Empir Bioeth       Date:  2021-10-13

6.  The New Precision Stewards?

Authors:  Karen M Meagher; Sara Watson; Gina A Suh; Abinash Virk
Journal:  J Pers Med       Date:  2022-08-12

7.  Health Equity and Implementation Science in Heart, Lung, Blood, and Sleep-Related Research: Emerging Themes From the 2018 Saunders-Watkins Leadership Workshop.

Authors:  Madeline R Sterling; Sandra E Echeverría; Yvonne Commodore-Mensah; Jessica Y Breland; Marcella Nunez-Smith
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2019-10-15

8.  Can Precision Medicine Reduce the Burden of Diabetes?

Authors:  Wylie Burke; Susan Brown Trinidad; David Schenck
Journal:  Ethn Dis       Date:  2019-12-12       Impact factor: 2.006

9.  Transparency, trust, and community welfare: towards a precision public health ethics framework for the genomics era.

Authors:  Eric T Juengst; Annelies Van Rie
Journal:  Genome Med       Date:  2020-11-20       Impact factor: 11.117

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.